Neumora Therapeutics, Inc. (NMRA) Tops Q3 EPS by 20c

Neumora Therapeutics, Inc. (NASDAQ: NMRA) reported Q3 EPS of ($0.45), $0.20 better than the analyst estimate of ($0.65).

For earnings history and earnings-related data on Neumora Therapeutics, Inc. (NMRA) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• OLB Group narrows net loss 50% as revenue falls in Q2 2026
• SpaceX (SPCX) gains nearly 6% as traders follow the money